Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Form 8.3 - [Devro plc - 16 12 2022] - (CGWL)
-
Full Year Results and Notice of AGM
-
Exercise of Share Options
-
Agrify Corp. (AGFY) Prices Public Offering of Common Stock, Warrants
-
Form 8.3 - [Devro plc - 15 12 2022] - (CGWL)
-
Advent to buy satellite operator Maxar Technologies for about $4 billion
-
Canaccord Genuity Starts Enero Group Ltd (EGG:AU) at Buy
-
Agrify Corp. (AGFY) to offer common stock
-
Form 8.3 - [Devro plc - 14 12 2022] - (CGWL)
-
Olive Resource Capital Announces Normal Course Issuer Bid
-
New Found Closes $50 Million Bought Deal Financing, Led by Eric Sprott
-
Canaccord Starts Pagaya Tech (PGY) at Hold
-
Touchstone Announces Closing of Canadian Private Placement
-
Full Circle Lithium Inc. Announces $10 Million Brokered Financing Connected to Go-Public Transaction with ESG Capital 1 Inc.
-
AEON Biopharma to Become Publicly Listed via Merger with Priveterra Acquisition Corp.; Accelerating Clinical Development of ABP-450 (prabotulinumtoxinA) Injection to Treat Debilitating Medical Conditi
-
Converge Technology Solutions Corp. Announces Houlihan Lokey Capital, Inc and Canaccord Genuity Corp as Co-financial Advisors
-
Form 8.3 - [Devro plc - 09 12 2022] - (CGWL)
-
Toubani Resources Commences Drill Program
-
ADENTRA Inc (ADEN:CN) PT Raised to Cdn$34 at Canaccord Genuity
-
Québec Nickel Corp. Announces Closing of the First Tranche of Its Previously Announced Private Placement
-
Form 8.3 - [K3 Capital Group plc - 08 12 2022 - Opening Declaration] - (CGAML)
-
Form 8.3 - [In the Style Group plc - 08 12 2022 - Opening Declaration] - (CGAML)
-
Form 8.3 - [Devro plc - 08 12 2022] - (CGWL)
-
Small Pharma to Participate in Upcoming Canaccord Genuity Investor Symposium
-
Small Pharma to Participate in Upcoming Canaccord Genuity Investor Symposium
-
Sanmina (SANM) Announces David V. Hedley III Joins Board Of Directors
-
DAVID V. HEDLEY III JOINS SANMINA'S BOARD OF DIRECTORS
-
Winc Obtains Court Approval of "First Day" Motions and Receives Notice of Delisting After Filing Chapter 11 Petitions
-
Form 8.3 - [EMIS Group plc - 07 12 2022] - (CGAML)
-
Form 8.3 - [Devro plc - 07 12 2022] - (CGWL)
-
BioNxt Solutions Announces Closing of Fully Subscribed Private Placement of Convertible Debentures
-
Form 8.3 - [Devro plc - 06 12 2022] - (CGWL)
-
Major Silicon Carbide Semiconductor Supplier Chooses Aehr for Production Wafer Level Test and Burn-in with Initial FOX-XP and Integrated Automated WaferPak Aligner Order
-
Touchstone Raises Approximately US$13 Million in Connection with UK and Canadian Fundraising
-
QuoteMedia to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
-
Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences in December
-
Mindset Pharma to Participate in Upcoming Conferences in December 2022
-
Form 8.3 - [Devro plc - 05 12 2022] - (CGWL)
-
Canadian Private Placement and Proposed UK Placing to Accelerate Exploration and Development at Ortoire
-
Wallbox Announces Virtual Investor Event with Canaccord Genuity
-
Canaccord Genuity Starts Latin Resources Ltd (LRS:AU) at Spec. Buy
-
Form 8.3 - [Devro plc - 02 12 2022] - (CGWL)
-
Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Sto
-
Form 8.3 - [Devro plc - 01 12 2022] - (CGWL)
-
Cohen Milstein代表Northwest Biotherapeutics对主要做市商操纵市场提起诉讼
-
Cohen Milstein代表Northwest Biotherapeutics對主要做市商操縱市場提起訴訟
-
Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation
-
Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation
-
Cohen Milstein reicht im Namen von Northwest Biotherapeutics Klage gegen die wichtigsten Market Maker wegen Marktmanipulation ein
-
RCI CFO Bradley Chhay Participates in Water Tower Research Video Series

